Description
The IVD Market in Vietnam
The IVD Market in Vietnam provides an overview of the in vitro diagnostics market in Vietnam and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in Vietnam, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious disease immunoassays, other immunoassays, blood bank screening immunoassays, POC glucose, POC other, ID/AST, microbiology molecular, HPV, CTC, other histology, and others.
The report provides Vietnam in vitro diagnostic revenues by broad market segments for 2017 and 2022, comprising clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology. Also included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
INDUSTRY OVERVIEW
SCOPE AND METHODOLOGY
VIETNAM IVD MARKET SUMMARY
Figure 1-1: Vietnam In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)
CHAPTER 2: VIETNAM OVERVIEW
POPULATION
Table 2-1: Total Midyear Population by Broad Age Group: Vietnam (million persons), 2010-2050
Figure 2-1: Total Midyear Population by Broad Age Group: Vietnam (million persons), 2010-2050
Figure 2-2: Total Number of Births in Vietnam by Year, 1990-2010 and Forecast 2020-2050
Figure 2-3: Vietnam Life Expectancy at Birth in Years, 2010-2050
HEALTH INDICATORS
General Health
Disease Profiles in Vietnam
Table 2-2: Top 5 Cancers Affecting Vietnamese Population (ranked by total number of cases), 2010-2015 .. 9
ECONOMY AND HEALTH SPENDING
Figure 2-4: Vietnam GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
Figure 2-5: Vietnam Distribution of Income or Consumption by Quintile, 2001-2014
HEALTH INFRASTRUCTURE
Medical Facilities
Figure 2-6: Hospital Bed Density per 1,000 Population by Country, 2017 Estimates
Physicians and Health Professionals
Figure 2-7: Physician Density per 1,000 Population by Country, 2017 Estimates
Medical Device Regulation
Table 2-3: Market Divers and Inhibitors for Entering Vietnam’s Medical Device Market
CHAPTER 3: IVD MARKETS IN VIETNAM
MARKET SUMMARY
Table 3-1: Vietnam In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
Figure 3-1: Vietnam In Vitro Diagnostic Sales by Broad Market Segment, 2017 – 2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)
Figure 3-2: Vietnam In Vitro Diagnostic Sales by Broad Market Segment, 2017 Market Distribution (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other) (%)
CLINICAL CHEMISTRY
Figure 3-3: Vietnam – Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis), 2017 – 2022
IMMUNOASSAY
Figure 3-4: Vietnam – Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017 – 2022
MICROBIOLOGY/MOLECULAR
Figure 3-5: Vietnam – Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2017 – 2022
POINT-OF-CARE
Figure 3-6: Vietnam – POC Market Value by Segment (Glucose, Infectious Disease, Others), 2017 – 2022
HISTOLOGY
Figure 3-7: Vietnam – Histology Market (HPV, CTC, Others), 2017 – 2022
